Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Fidaxomicin is an antibiotic carefully developed by Optimer to treat refractory Clostridium infections and has demonstrated excellent efficacy and safety through a unique mechanism···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：629
Fidaxomicinis an innovative macrolide antibiotic that has demonstrated its potent therapeutic ability against refractory Clostridium infections by blocking bacterial RNA polymerase···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：604
Fidaxomicinis a new star of macrolide antibiotics developed by Optimer, which has a specific effect on refractory Clostridium infection and has demonstrated excellent therapeutic p···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：547
Fidaxomicin is a cutting-edge antibiotic developed by Optimer that specializes in refractory Clostridium infections and ushers a new chapter in anti-infective therapy by inhibiting···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：553
Fidaxomicinis an innovative macrolide antibiotic developed by Optimer, which has demonstrated excellent efficacy and safety by blocking bacterial RNA polymerase for the targeted tr···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：538
Fidaxomicin is a macrolide antibiotic from Optimer, which brings an efficient and safe treatment regimen for patients with refractory Clostridium infection with its unique RNA poly···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：541
Fidaxomicin is an innovative drug carefully developed by Optimer, specially designed for the treatment of refractory Clostridium infection, by blocking bacterial RNA polymerase, en···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：504
Fidaxomicin is an antibiotic developed by Optimer, which targets the unique mechanism of refractory Clostridium and can effectively inhibit RNA polymerase, ensuring clinically effi···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：594
Fidaxomicin is an innovative macrolide antibiotic developed by Optimer, which is designed for the treatment of refractory Clostridium infections with its unique RNA polymerase inhi···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：543
Fidaxomicinis an innovative antibiotic designed to treat diarrhea caused by Clostridium difficile by inhibiting bacterial growth through a unique mechanism that reduces interferenc···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：597
Fidaxomicin is an innovative antibiotic designed to treat diarrhea caused by Clostridium difficile by inhibiting bacterial growth through a unique mechanism that reduces interferen···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：578
Fidaxomicin is a new macrolide antibiotic used for the treatment of Clostridium difficile-associated diarrhea by inhibiting bacterial RNA polymerase and has little effect on the no···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：637
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8532025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10502024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：3132026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4062026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：5992026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：5752026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4582026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6082026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
